IDEAS home Printed from https://ideas.repec.org/a/bjc/journl/v8y2021i2p135-165.html
   My bibliography  Save this article

Role of herbal medicine for controlling coronavirus (SARS-CoV-2) disease (COVID-19)

Author

Listed:
  • Ravindra B. Malabadi

    (Department of Applied Botany, Mangalore University, Mangalagangotri-574199, Mangalore, Karnataka State, India)

  • Neelambika T. Meti

    (Plant Biotechnology Laboratory, Rajiv Gandhi Institute of IT and Biotechnology, Bharati Vidyapeeth University, Pune-Satara Road, Katraj, Pune – 411046, Maharashtra State, India)

  • Raju K. Chalannavar

    (Department of Applied Botany, Mangalore University, Mangalagangotri-574199, Mangalore, Karnataka State, India)

Abstract

This review paper highlights the use of herbal medicine in the management of the coronavirus disease COVID-19 (SARS-CoV-2) pandemic, which has caused a worldwide outbreak of respiratory illness. This is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which is zoonotic infecting both animal and human. Vaccines are the most promising solution to mitigate new viral strains. The Indian system of holistic medicine known as “Ayurveda†plays an important role in controling the viral disease SARS-CoV-2 and other health disorders. Dietary therapy and herbal medicine could be a complementary preventive therapy for COVID-19 (SARS-CoV-2). Plants have been used as a expression systems for the production of diagnostic reagents and pharmaceutical proteins often described as ‘molecular farming. On the basis of literature survy presented, some of the plant secondary metabolites that showed prominent antiviral activity against coronaviruses SARS-CoV-2 through impeding the main machinery used in their pathogenesis and replication cycle. The in vitro, in vivo, and in silico investigations revealed numerous plant-derived compounds with promising anti- SARS-CoV and anti- SARS CoV-2 activity. Therefore, this review gathered all antiviral plants in a single platform to facilitate the laboratory-based research for the development of novel drug/molecular therapeutics to overcome the SARS-CoV-2 and future pandemic situations. Further detailed clinical trial experiments should be conducted for the scientific validation.

Suggested Citation

  • Ravindra B. Malabadi & Neelambika T. Meti & Raju K. Chalannavar, 2021. "Role of herbal medicine for controlling coronavirus (SARS-CoV-2) disease (COVID-19)," International Journal of Research and Scientific Innovation, International Journal of Research and Scientific Innovation (IJRSI), vol. 8(2), pages 135-165, February.
    • Handle: RePEc:bjc:journl:v:8:y:2021:i:2:p:135-165
    as

    Download full text from publisher

    File URL: https://www.rsisinternational.org/journals/ijrsi/digital-library/volume-8-issue-2/135-165.pdf
    Download Restriction: no
    File URL: https://www.rsisinternational.org/virtual-library/papers/role-of-herbal-medicine-for-controlling-coronavirus-sars-cov-2-disease-covid-19/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Jing-Hui Tian & Nita Patel & Robert Haupt & Haixia Zhou & Stuart Weston & Holly Hammond & James Logue & Alyse D. Portnoff & James Norton & Mimi Guebre-Xabier & Bin Zhou & Kelsey Jacobson & Sonia Macie, 2021. "SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice," Nature Communications, Nature, vol. 12(1), pages 1-14, December.
    2. Wenhui Li & Michael J. Moore & Natalya Vasilieva & Jianhua Sui & Swee Kee Wong & Michael A. Berne & Mohan Somasundaran & John L. Sullivan & Katherine Luzuriaga & Thomas C. Greenough & Hyeryun Choe & M, 2003. "Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus," Nature, Nature, vol. 426(6965), pages 450-454, November.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Behrooz Darbani, 2020. "The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues," IJERPH, MDPI, vol. 17(10), pages 1-8, May.
    2. Shanlin Ke & Scott T. Weiss & Yang-Yu Liu, 2022. "Dissecting the role of the human microbiome in COVID-19 via metagenome-assembled genomes," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    3. Indrikis A. Krams & Priit Jõers & Severi Luoto & Giedrius Trakimas & Vilnis Lietuvietis & Ronalds Krams & Irena Kaminska & Markus J. Rantala & Tatjana Krama, 2021. "The Obesity Paradox Predicts the Second Wave of COVID-19 to Be Severe in Western Countries," IJERPH, MDPI, vol. 18(3), pages 1-10, January.
    4. Alice Latinne & Ben Hu & Kevin J. Olival & Guangjian Zhu & Li-Biao Zhang & Hongying Li & Aleksei A. Chmura & Hume E. Field & Carlos Zambrana-Torrelio & Jonathan H. Epstein & Bei Li & Wei Zhang & Lin-F, 2024. "Origin and cross-species transmission of bat coronaviruses in China," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    5. Hisano Yajima & Yuki Anraku & Yu Kaku & Kanako Terakado Kimura & Arnon Plianchaisuk & Kaho Okumura & Yoshiko Nakada-Nakura & Yusuke Atarashi & Takuya Hemmi & Daisuke Kuroda & Yoshimasa Takahashi & Shu, 2024. "Structural basis for receptor-binding domain mobility of the spike in SARS-CoV-2 BA.2.86 and JN.1," Nature Communications, Nature, vol. 15(1), pages 1-14, December.
    6. Kin Wah Fung & Seo H Baik & Fitsum Baye & Zhaonian Zheng & Vojtech Huser & Clement J McDonald, 2022. "Effect of common maintenance drugs on the risk and severity of COVID-19 in elderly patients," PLOS ONE, Public Library of Science, vol. 17(4), pages 1-15, April.
    7. Milad Haghani & Pegah Varamini, 2021. "Temporal evolution, most influential studies and sleeping beauties of the coronavirus literature," Scientometrics, Springer;Akadémiai Kiadó, vol. 126(8), pages 7005-7050, August.
    8. Caner Akıl & Jialu Xu & Juan Shen & Peijun Zhang, 2025. "Unveiling the structural spectrum of SARS-CoV-2 fusion by in situ cryo-ET," Nature Communications, Nature, vol. 16(1), pages 1-12, December.
    9. Diego Fernández-Lázaro & Jerónimo J. González-Bernal & Nerea Sánchez-Serrano & Lourdes Jiménez Navascués & Ana Ascaso-del-Río & Juan Mielgo-Ayuso, 2020. "Physical Exercise as a Multimodal Tool for COVID-19: Could It Be Used as a Preventive Strategy?," IJERPH, MDPI, vol. 17(22), pages 1-13, November.
    10. Weiwei Ji & Qi Peng & Xueqiong Fang & Zehou Li & Yaxin Li & Cunfa Xu & Shuqing Zhao & Jizong Li & Rong Chen & Guoxiang Mo & Zhanyong Wei & Ying Xu & Bin Li & Shuijun Zhang, 2022. "Structures of a deltacoronavirus spike protein bound to porcine and human receptors," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    11. Shubhadeep Roychoudhury & Anandan Das & Pallav Sengupta & Sulagna Dutta & Shatabhisha Roychoudhury & Arun Paul Choudhury & A. B. Fuzayel Ahmed & Saumendra Bhattacharjee & Petr Slama, 2020. "Viral Pandemics of the Last Four Decades: Pathophysiology, Health Impacts and Perspectives," IJERPH, MDPI, vol. 17(24), pages 1-39, December.
    12. Marysia Wrona & Damian Skrypnik, 2022. "New-Onset Diabetes Mellitus, Hypertension, Dyslipidaemia as Sequelae of COVID-19 Infection—Systematic Review," IJERPH, MDPI, vol. 19(20), pages 1-10, October.
    13. Fabian Zech & Daniel Schniertshauer & Christoph Jung & Alexandra Herrmann & Arne Cordsmeier & Qinya Xie & Rayhane Nchioua & Caterina Prelli Bozzo & Meta Volcic & Lennart Koepke & Janis A. Müller & Jan, 2021. "Spike residue 403 affects binding of coronavirus spikes to human ACE2," Nature Communications, Nature, vol. 12(1), pages 1-10, December.
    14. Nagla A. El-Shitany & Manal El-Hamamsy & Ahlam A. Alahmadi & Basma G. Eid & Thikryat Neamatallah & Haifa S. Almukadi & Rana A. Arab & Khadija A. Faddladdeen & Khayria A. Al-Sulami & Safia M. Bahshwan , 2021. "The Impact of ABO Blood Grouping on COVID-19 Vulnerability and Seriousness: A Retrospective Cross-Sectional Controlled Study among the Arab Community," IJERPH, MDPI, vol. 18(1), pages 1-19, January.
    15. Ma’ayan Israeli & Yaara Finkel & Yfat Yahalom-Ronen & Nir Paran & Theodor Chitlaru & Ofir Israeli & Inbar Cohen-Gihon & Moshe Aftalion & Reut Falach & Shahar Rotem & Uri Elia & Ital Nemet & Limor Klik, 2022. "Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    16. Charulata Jindal & Sandeep Kumar & Sunil Sharma & Yuk Ming Choi & Jimmy T. Efird, 2020. "The Prevention and Management of COVID-19: Seeking a Practical and Timely Solution," IJERPH, MDPI, vol. 17(11), pages 1-11, June.
    17. Tomasz Gęca & Kamila Wojtowicz & Paweł Guzik & Tomasz Góra, 2022. "Increased Risk of COVID-19 in Patients with Diabetes Mellitus—Current Challenges in Pathophysiology, Treatment and Prevention," IJERPH, MDPI, vol. 19(11), pages 1-17, May.
    18. Shouheng Jin & Xing He & Ling Ma & Zhen Zhuang & Yiliang Wang & Meng Lin & Sihui Cai & Lu Wei & Zheyu Wang & Zhiyao Zhao & Yaoxing Wu & Lin Sun & Chunwei Li & Weihong Xie & Yong Zhao & Zhou Songyang &, 2022. "Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    19. Rafael R. G. Machado & Jordyn L. Walker & Dionna Scharton & Grace H. Rafael & Brooke M. Mitchell & Rachel A. Reyna & William M. Souza & Jianying Liu & David H. Walker & Jessica A. Plante & Kenneth S. , 2023. "Immunogenicity and efficacy of vaccine boosters against SARS-CoV-2 Omicron subvariant BA.5 in male Syrian hamsters," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    20. Mohamed A. Farrag & Haitham M. Amer & Rauf Bhat & Maaweya E. Hamed & Ibrahim M. Aziz & Ayman Mubarak & Turki M Dawoud & Sami G Almalki & Fayez Alghofaili & Ahmad K. Alnemare & Raid Saleem Al-Baradi & , 2021. "SARS-CoV-2: An Overview of Virus Genetics, Transmission, and Immunopathogenesis," IJERPH, MDPI, vol. 18(12), pages 1-14, June.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bjc:journl:v:8:y:2021:i:2:p:135-165. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Dr. Renu Malsaria (email available below). General contact details of provider: https://rsisinternational.org/journals/ijrsi/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.